Efficacy, pharmacokinetics, and tolerability of subcutaneous secukinumab injections with 2 mL prefilled syringes (300 mg) in adult subjects with moderate to severe plaque psoriasis
Sigurgeirsson B, Schäkel K, Hong C-H, Effendy I, Placek W, Rich P, Bruin G, Charef P, Fu R, Hampele I, Patekar M (2021)
Journal of the American Academy of Dermatology 85(3, Suppl.): AB150.
Kurzbeitrag Konferenz / Poster
| Veröffentlicht | Englisch
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
Sigurgeirsson, Bardur;
Schäkel, Knut;
Hong, Chih-Ho;
Effendy, IsaakUniBi 
;
Placek, Waldemar;
Rich, Phoebe;
Bruin, Gerard;
Charef, Pascal;
Fu, Rong;
Hampele, Isabelle;
Patekar, Manmath
;
Placek, Waldemar;
Rich, Phoebe;
Bruin, Gerard;
Charef, Pascal;
Fu, Rong;
Hampele, Isabelle;
Patekar, ManmathErscheinungsjahr
2021
Serien- oder Zeitschriftentitel
Journal of the American Academy of Dermatology
Band
85
Ausgabe
3, Suppl.
Seite(n)
AB150
ISSN
0190-9622
eISSN
1097-6787
Page URI
https://pub.uni-bielefeld.de/record/2968741
Zitieren
Sigurgeirsson B, Schäkel K, Hong C-H, et al. Efficacy, pharmacokinetics, and tolerability of subcutaneous secukinumab injections with 2 mL prefilled syringes (300 mg) in adult subjects with moderate to severe plaque psoriasis. Journal of the American Academy of Dermatology. 2021;85(3, Suppl.):AB150.
Sigurgeirsson, B., Schäkel, K., Hong, C. - H., Effendy, I., Placek, W., Rich, P., Bruin, G., et al. (2021). Efficacy, pharmacokinetics, and tolerability of subcutaneous secukinumab injections with 2 mL prefilled syringes (300 mg) in adult subjects with moderate to severe plaque psoriasis. Journal of the American Academy of Dermatology, 85(3, Suppl.), AB150. https://doi.org/10.1016/j.jaad.2021.06.614
Sigurgeirsson, Bardur, Schäkel, Knut, Hong, Chih-Ho, Effendy, Isaak, Placek, Waldemar, Rich, Phoebe, Bruin, Gerard, et al. 2021. “Efficacy, pharmacokinetics, and tolerability of subcutaneous secukinumab injections with 2 mL prefilled syringes (300 mg) in adult subjects with moderate to severe plaque psoriasis”, Journal of the American Academy of Dermatology, 85 (3, Suppl.): AB150.
Sigurgeirsson, B., Schäkel, K., Hong, C. - H., Effendy, I., Placek, W., Rich, P., Bruin, G., Charef, P., Fu, R., Hampele, I., et al. (2021). Efficacy, pharmacokinetics, and tolerability of subcutaneous secukinumab injections with 2 mL prefilled syringes (300 mg) in adult subjects with moderate to severe plaque psoriasis. Journal of the American Academy of Dermatology 85, AB150.
Sigurgeirsson, B., et al., 2021. Efficacy, pharmacokinetics, and tolerability of subcutaneous secukinumab injections with 2 mL prefilled syringes (300 mg) in adult subjects with moderate to severe plaque psoriasis. Journal of the American Academy of Dermatology, 85(3, Suppl.), p AB150.
B. Sigurgeirsson, et al., “Efficacy, pharmacokinetics, and tolerability of subcutaneous secukinumab injections with 2 mL prefilled syringes (300 mg) in adult subjects with moderate to severe plaque psoriasis”, Journal of the American Academy of Dermatology, vol. 85, 2021, pp. AB150.
Sigurgeirsson, B., Schäkel, K., Hong, C.-H., Effendy, I., Placek, W., Rich, P., Bruin, G., Charef, P., Fu, R., Hampele, I., Patekar, M.: Efficacy, pharmacokinetics, and tolerability of subcutaneous secukinumab injections with 2 mL prefilled syringes (300 mg) in adult subjects with moderate to severe plaque psoriasis. Journal of the American Academy of Dermatology. 85, AB150 (2021).
Sigurgeirsson, Bardur, Schäkel, Knut, Hong, Chih-Ho, Effendy, Isaak, Placek, Waldemar, Rich, Phoebe, Bruin, Gerard, Charef, Pascal, Fu, Rong, Hampele, Isabelle, and Patekar, Manmath. “Efficacy, pharmacokinetics, and tolerability of subcutaneous secukinumab injections with 2 mL prefilled syringes (300 mg) in adult subjects with moderate to severe plaque psoriasis”. Journal of the American Academy of Dermatology 85.3, Suppl. (2021): AB150.
Export
Markieren/ Markierung löschen
Markierte Publikationen
Web of Science
Dieser Datensatz im Web of Science®Suchen in
Google Scholar